Research progress on Syndrome Types and Prescription Medication of Traditional Chinese Medicine of EGFR-TKI Patients Treated by Molecular Targeted Therapy of Lung Cancer
Epidermal growth factor receptor tyrosine kinase inhibitor(EGFR-TKI)is a milestone in the field of lung cancer treatment,and the combination of traditional Chinese medicine and molecular targeted therapy EGFR-TKI is a new mode of com-prehensive treatment of lung cancer.The treatment based on syndrome differentiation is the characteristic of traditional Chinese medicine.The precise cooperation of traditional Chinese medicine can run through the whole process of molecular targeted treat-ment of EGFR-TKI.Through consulting,summarizing and analyzing the literature of different experts and scholars in recent years on the research of TCM syndromes and TCM prescriptions for different treatment stages of molecular targeted treatment of EGFR-TKI related lung cancer patients,it summarized the distribution of syndromes and the characteristics of TCM prescriptions for different treatment stages of EGFR-TKI patients with molecular targeted treatment of lung cancer,so as to promote the accu-racy of TCM syndrome differentiation and treatment,the aim is to further improve the clinical efficacy of traditional Chinese medi-cine combined with molecular targeted therapy of EGFR-TKI.
lung cancermolecular targeted therapyepidermal growth factor receptor tyrosine kinase inhibitorsyndrome typesprescription medication of traditional Chinese medicine
NETL
NSTL
万方数据
